Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
about
Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure.Lack of effect of smoking status on axitinib pharmacokinetics in patients with non-small-cell lung cancer.The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma.Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics.
P2860
Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
@en
Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
@nl
type
label
Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
@en
Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
@nl
prefLabel
Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
@en
Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
@nl
P2093
P2860
P1476
Pharmacokinetics of single-agent axitinib across multiple solid tumor types
@en
P2093
Ezra E W Cohen
John P Fruehauf
May Garrett
Michael A Tortorici
Yazdi K Pithavala
P2860
P2888
P304
P356
10.1007/S00280-014-2606-6
P577
2014-10-22T00:00:00Z